Skip to main content

Kalaris Therapeutics, Inc.

KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001754068

No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q3 2026, worth $49.8M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Kalaris Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
−2 vs. Q2 2026
Shares held
17.2M
−806.6K (−4.5%) vs. Q2 2026
Total value
$49.8M
−$23.6M (−32.2%) vs. Q2 2026
New holders
6
13 more added
Sold out
8
20 more reduced

1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KLRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 53 institutions
Q1 2021: 75 institutionsQ2 2021: 84 institutionsQ3 2021: 80 institutionsQ4 2021: 84 institutionsQ1 2022: 84 institutionsQ2 2022: 84 institutionsQ3 2022: 87 institutionsQ4 2022: 86 institutionsQ1 2023: 89 institutionsQ2 2023: 94 institutionsQ3 2023: 90 institutionsQ4 2023: 82 institutionsQ1 2024: 77 institutionsQ2 2024: 72 institutionsQ3 2024: 60 institutionsQ4 2024: 53 institutionsQ1 2025: 32 institutionsQ2 2025: 30 institutionsQ3 2025: 32 institutionsQ4 2025: 51 institutionsQ1 2026: 58 institutionsQ2 2026: 56 institutionsQ3 2026: 53 institutions
Value heldQ3 2026: $49.8M
Q1 2021: $624.4MQ2 2021: $521.8MQ3 2021: $640.3MQ4 2021: $329.4MQ1 2022: $184.1MQ2 2022: $109.6MQ3 2022: $293.7MQ4 2022: $193.1MQ1 2023: $156.0MQ2 2023: $183.6MQ3 2023: $115.5MQ4 2023: $28.5MQ1 2024: $36.4MQ2 2024: $33.9MQ3 2024: $36.3MQ4 2024: $20.7MQ1 2025: $111.4MQ2 2025: $35.7MQ3 2025: $76.4MQ4 2025: $151.9MQ1 2026: $107.2MQ2 2026: $73.4MQ3 2026: $49.8M
Institutions holding KLRS and their total value by quarter
QuarterHoldersValue
Q3 202653$49.8M
Q2 202656$73.4M
Q1 202658$107.2M
Q4 202551$151.9M
Q3 202532$76.4M
Q2 202530$35.7M
Q1 202532$111.4M
Q4 202453$20.7M
Q3 202460$36.3M
Q2 202472$33.9M
Q1 202477$36.4M
Q4 202382$28.5M
Q3 202390$115.5M
Q2 202394$183.6M
Q1 202389$156.0M
Q4 202286$193.1M
Q3 202287$293.7M
Q2 202284$109.6M
Q1 202284$184.1M
Q4 202184$329.4M
Q3 202180$640.3M
Q2 202184$521.8M
Q1 202175$624.4M

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Kalaris Therapeutics, Inc.; share changes are against Q2 2026.

Institutions holding KLRS in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Samsara BioCapital, LLC12,881,175$37.2M3.54%00.0%Unchanged
RTW Investments, LP1,300,000$3.76M0.04%00.0%Unchanged
Alyeska Investment Group, L.P.472,687$1.37M0.00%−100,000−17.5%Reduced
Siren, L.L.C.356,559$1.03M0.02%−79,239−18.2%Reduced
Vanguard Capital Management LLC330,928$956.4K0.00%−67,784−17.0%Reduced
Ikarian Capital, LLC248,257$717.5K0.14%−111,743−31.0%Reduced
Renaissance Technologies LLC176,863$511.1K0.00%+27,512+18.4%Added
Verdad Advisers, LP140,232$405.3K0.43%+59,935+74.6%Added
UBS Group AG110,187$318.4K0.00%−151,944−58.0%Reduced
Raymond James Financial Inc101,496$293.3K0.00%+4,332+4.5%Added
Whi Trust Co LLC97,493$281.8K0.16%00.0%Unchanged
Woodline Partners LP90,000$260.1K0.00%−10,000−10.0%Reduced
Geode Capital Management, LLC78,859$228.0K0.00%−35,178−30.8%Reduced
Boothbay Fund Management, LLC63,623$183.9K0.00%−28,638−31.0%Reduced
ADAR1 Capital Management, LLC60,000$173.4K0.01%−40,000−40.0%Reduced
BlackRock, Inc.58,619$169.4K0.00%+4,177+7.7%Added
State Street Corp51,210$148.0K0.00%+24,700+93.2%Added
Vanguard Fiduciary Trust Co47,553$137.4K0.00%−18,626−28.1%Reduced
Belpointe Asset Management LLC40,000$115.6K0.00%00.0%Unchanged
Fortis Capital Advisors, LLC40,000$115.6K0.01%00.0%Unchanged
Goldman Sachs Group Inc39,616$114.5K0.00%+23,562+146.8%Added
Citadel Advisors LLC39,219$113.3K0.00%−56,553−59.0%Reduced
Connor, Clark & Lunn Investment Management Ltd.35,678$103.1K0.00%+5,671+18.9%Added
Stonepine Capital Management, LLC33,842$97.8K0.08%+3,720+12.3%Added
Morgan Stanley26,773$77.4K0.00%−45,553−63.0%Reduced
Northern Trust Corp25,833$74.7K0.00%−60.0%Reduced
HRT Financial LP25,560$73.0K0.00%+11,837+86.3%Added
Velan Capital Investment Management LP25,000$72.3K0.07%00.0%Unchanged
WealthTrust Asset Management, LLC23,604$68.2K0.04%+3,188+15.6%Added
Quadrature Capital Ltd23,287$67.3K0.00%+6,760+40.9%Added
Bridgeway Capital Management, LLC22,500$65.0K0.00%−10,000−30.8%Reduced
Empowered Funds, LLC22,500$65.0K0.00%+22,500New
Jane Street Group, LLC19,594$56.6K0.00%+19,594New
Squarepoint Ops LLC18,947$54.8K0.00%−19,828−51.1%Reduced
RBF Capital, LLC17,391$50.3K0.00%00.0%Unchanged
Dimensional Fund Advisors LP15,958$46.1K0.00%00.0%Unchanged
XTX Topco Ltd14,726$42.6K0.00%+14,726New
Nano Cap New Millennium Growth Fund L P14,000$40.5K0.03%+1,500+12.0%Added
Independent Advisor Alliance12,625$36.5K0.00%−5,500−30.3%Reduced
FMR LLC7,806$22.6K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec6,000$17.3K0.00%+6,000New
Nuveen, LLC4,639$13.5K0.00%+4,639New
Caitong International Asset Management Co., Ltd1,559$4.51K0.00%+1,552+22,171.4%Added
Tower Research Capital LLC (TRC)838$2.42K0.00%−1,722−67.3%Reduced
Vanguard Global Advisers, LLC725$2.10K0.00%00.0%Unchanged
Strengthening Families & Communities, LLC268$7750.00%00.0%Unchanged
JPMorgan Chase & Co50$1450.00%00.0%Unchanged
BNP Paribas Arbitrage, SA46$1330.00%−6−11.5%Reduced
Steward Partners Investment Advisory, LLC21$610.00%−2,194−99.1%Reduced
Barclays PLC17$490.00%−286−94.4%Reduced
Harbour Investments, Inc.13$380.00%00.0%Unchanged
SBI Securities Co., Ltd.5$140.00%00.0%Unchanged
Citigroup Inc1$30.00%+1New
Marshall Wace, LLP0$00.00%−139,201−100.0%Sold out
Pale Fire Capital SE0$00.00%−39,626−100.0%Sold out
Trexquant Investment LP0$00.00%−29,737−100.0%Sold out
Two Sigma Investments, LP0$00.00%−23,847−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−14,221−100.0%Sold out
Virtu Financial LLC0$00.00%−10,845−100.0%Sold out
Sigma Planning Corp0$00.00%−10,167−100.0%Sold out
Parallel Advisors, LLC0$00.00%−49−100.0%Sold out
Royal Bank of Canada––––Not filed